Braemar Hotels (BHR): Proxy Fight, Dec 21 Vote, Ashford Split

What was filed on October 14, and by whom

Two things in the search results are easy to mix up. Braemar did not file the October 14 document; a stockholder did. The filer is Brancous, LP1, with its general partner Brancous Investments Corporation, and the form is a PREC14A: a preliminary proxy statement from a party other than the company, marked “preliminary copy, subject to completion.” Several blanks, including the share counts on the record date, are still empty. It is a draft until a definitive version (DEFC14A) is filed.

The page you may have seen quoted in search results, the June 12 “conclusion of strategic review” press release, is the company's announcement, not the filing above. We read both and keep them apart below.

The nominees are individuals named in the filing; we do not profile them here. Their biographies are in the PREC14A, and the company's candidates will be in Braemar's own proxy statement when it is filed.

The timeline, from the August 2025 fee letter to the December 21 vote

What each side says

These are claims, quoted from each side's own document. We have not checked them against court dockets, and Braemar has not yet filed a response to the PREC14A.

Brancous's case, in its own words, has three parts. First, that Ashford has first claim on sale proceeds and the common stock is worth little beside it: at a $1.65 close on October 1, it values the 68,679,318 common shares at about $113.3 million, “less than one-quarter of the $480 million discounted fee alone” (that is 23.6%, our arithmetic). Second, that the directors who agreed the fee should not choose their successors. Third, that the board resisted nominations instead of engaging. Its stated priorities include an independent strategic review, “meaningful distributions where appropriate” and a review of how the termination was calculated and documented. It also says the other nominees “have not committed to any particular plan.”

Braemar's case, from its June 12 and October 8 releases, is that the separation cuts annual corporate costs from about $42 million to about $15 million, that new independent directors are already being recruited through an executive search firm, and that sales plus refinancings are “expected to generate sufficient funds to pay the remainder” of the fees. It also points to an earlier endorsement of the June 12 plan from another stockholder, Blackwells Capital, in a July 22 filing; we have not read Blackwells's own release.

Where the documents do not agree. Reading both sides against the SEC filings turns up four gaps worth knowing:

• Hotel count and total. The PREC14A says Braemar “sold four hotels for a combined $627.5 million and agreed to sell a fifth for $372 million.” That leaves out Park Hyatt Beaver Creek ($176 million, May 26, 2026). With it, five hotels are sold for $803.5 million, plus Scottsdale at $372 million, which matches the same filing's later “six of its hotels” and the drop from 13 hotels to 7 (our arithmetic).
• Pier House closing date. The August 17 8-K says August 12; the October 8 press release says August 21. The PREC14A footnote flags the same difference. We use August 12 (the filed 8-K) and note the other.
• Meeting date. Several summaries still say November 13. That was the date set on September 3; it moved to December 21 on September 23.
• The discount. $574.8 million less $480.0 million is $94.8 million (our arithmetic). A Blackwells statement quoted in Braemar's July 22 soliciting material says the renegotiation cut the amount owed by “approximately $94.3 million”; the filings we read give the two end points, not that number.

The Ashford fee and how it is being paid

Two clauses explain why the fee dominates the contest. The first is the order of payment: the fee comes from net sale proceeds “before any other payments, dividends or distributions are made,” so nothing reaches common stockholders until it is cleared. The second is that after the fee and the master agreement fee are paid in full, either side may end the advisory agreement on 60 days' written notice. Braemar says the separation should be complete by mid-November 2026, which is before the December 21 meeting; Brancous's filing addresses the case where the advisory agreement “has not been terminated before the Annual Meeting.”

Remember the March 31, 2026 notice: Ashford Inc. extended the advisory agreement to 2037 three months before Braemar announced it would end it. Amendment No. 3 (May 21, 2026) also kept open the window to renegotiate the base or incentive fee through December 31, 2026.

What a Brancous win would do, in Brancous's own reading. The filing says that if all five nominees are elected they would be a majority, which it says could count as a change of control under the advisory agreement and the 2013 equity incentive plan, adding: “A change of control under these arrangements could trigger termination or other fees or accelerate the vesting of equity awards.” It says it will ask the incumbent board to approve the nominees to avoid that. This is Brancous's reading of the contracts, not a ruling.

Six hotel sales and the seven left

What stays, per the October 8 press release and the twelve months to August 31, 2026 (unaudited, 8-K October 13):

Hotel EBITDA here is the company's non-GAAP measure and the 8-K gives no reconciliation to net income for the twelve months to August. For the twelve months to June 30, the company's own table shows the same seven hotels with a hotel net loss of $12.8 million against $87.9 million of Hotel EBITDA: depreciation and interest move a lot between those two lines. Q2 2026 itself was a quarter with comparable RevPAR up 12.3% to $396 and a net loss to common of $0.7 million.

Debt: what is due and what the company plans

At June 30, 2026 Braemar had $956.3 million of loans, all effectively floating-rate, at a blended 6.82%, and said it was in compliance with all covenants. It repaid its 4.50% convertible notes ($86.3 million) on June 1.

Cash was $93.9 million unrestricted and $52.6 million restricted at June 30. The company's plan, stated October 8, is a set of refinancings “over the next three to six months” that it expects to cut the weighted-average rate by more than 150 basis points (its slide says 154), save $4.8 to $5.5 million of interest in 2027 and push the first maturity to 2028; it projects net debt of about $405 million and net debt to gross assets of about 36% (from about 50%) on a pro forma basis. All of that is a projection. Until refinancings close, the Lake Tahoe loan, the Capital Hilton loan and the March 2027 loans are the dated items.

Dividends: common stock and preferred

Common. $0.05 a quarter in 2023, 2024 and 2025. In 2026 none: the 10-Q shows common dividends declared of zero for both the quarter and the six months, against $6.8 million in the first half of 2025, and says the board “has not declared a dividend policy for 2026.” The 10-K gave the reason as the sale process: proceeds might be distributed “after satisfying the Company's other obligations.” The October 8 guidance gives no common dividend figure. Its own numbers: NAREIT FFO of $0.23 to $0.30 a share on 74.3 million shares, about $19.3 million at the $0.26 midpoint (our arithmetic), and about $26 million a year of preferred dividends.

In Q2 2026 the four series together had $7.741 million of dividends in the earnings-per-share calculation (B $1.058 million, D $0.825 million, E $5.129 million, M $0.729 million). The board says it reviews the policy quarter by quarter and declaring a dividend commits it to nothing further.

Series E and M: the non-traded preferred and the vote

This is the part few quote pages cover. Braemar sold Series E and Series M redeemable preferred at $25 a share through Ashford Securities, a subsidiary of Ashford Inc.: about 16.4 million Series E shares for $369.5 million of net proceeds and about 2.0 million Series M shares for $47.6 million. Both are unlisted. Holders can ask Braemar to redeem at $25 plus accrued dividends, less a fee that has fallen to zero after the third anniversary of purchase, “subject to the limitations” in the charter documents.

Braemar says it expects all requests to be fulfilled “over the subsequent twelve months from June 30, 2026,” and its 2027 guidance assumes $8 million of redemptions in the fourth quarter and about $407 million of preferred equity outstanding at year-end. The unfulfilled queue grew from $30.2 million to $53.4 million in six months (our arithmetic for E), so the pace matters. If dividends on a series fall 18 or more monthly periods behind, its holders can elect two extra directors.

The vote. Series E and M holders vote with the common stock as one class, one vote per share. Using the April 30 preferred counts and the August 4 common count (different dates, so approximate), the two series are about 12.5 million of roughly 81.2 million votes, near 15% (our arithmetic). The preferred is a meaningful share of the electorate. The PREC14A leaves the record-date share counts blank; Braemar's own proxy statement will give the real figures.

What happens next, with dates

If the meeting runs as scheduled, the result will be on EDGAR within four business days, as the PREC14A itself says. The motion to dismiss in the case Braemar brought against Brancous has been fully briefed since June 26, 2026; a ruling date is not in any filing we read.

What a holder or interested reader can do with this

This page is analysis of public documents, not investment, legal or tax advice. The filings let you check these things yourself.

• Find out which class you hold. Common stock, Series E or M, listed Series B or D are different securities with different votes and cash. Your broker statement may show Series E or M at $25 a share, the stated value, not a market price.
• If you hold common or Series E or M on the December 21 record, you will receive a card from the company and, probably, a BLUE card from Brancous. The PREC14A warns that only the latest-dated card counts and that marking more than five candidates voids the vote on directors. Read both proxy statements when they are final; the one dated October 14 is a draft.
• For Series E and M holders: read the redemption note, not the headline. Requests above the charter limits go into a payable that grew to $57.8 million by July 31; the company says it expects to clear it within twelve months of June 30, 2026. A redemption request is a place in a queue, not a date.
• Test the common dividend against the order of payment. The fee goes first. The remaining $307.0 million (our arithmetic) plus accrued fees and the master agreement payment are claims on sale proceeds before any distribution.
• Compare with the sister company. Ashford Hospitality Trust is a different company, also advised by Ashford Inc., whose non-traded preferred is frozen and whose dividends were suspended; Braemar's preferred is still paying and redeeming. How a listed REIT with non-traded preferred differs from a non-traded REIT is in non-traded vs publicly traded REITs; how redemption limits have worked elsewhere is in the redemption suspension tracker.

For what an adviser costs on a position like this, see what a financial advisor costs for real estate investing. Another hotel vehicle with filing problems is covered on our Lodging Fund REIT III page.

FAQ

All figures are from SEC filings read on EDGAR on October 15, 2026. Braemar Hotels & Resorts Inc. (CIK 1574085): Form 10-Q for the quarter ended June 30, 2026 (accession 0001574085-26-000130); Form 10-K for 2025 (0001574085-26-000038); Forms 8-K of December 23, 2025 (0001104659-25-124212), April 3, 2026 (0001574085-26-000054), May 22 (0001574085-26-000087), June 12 (0001574085-26-000100), July 17 (0001574085-26-000116), August 5 (0001574085-26-000123), August 17 (0001574085-26-000132), September 4 (0001574085-26-000138), September 23 (0001574085-26-000141), September 29 (0001574085-26-000146), October 8 (0001574085-26-000151 and 0001104659-26-114693) and October 13 (0001574085-26-000153); the DEFA14A of July 22, 2026 (0001104659-26-085884); and the Brancous, LP1 Form PREC14A filed October 14, 2026 (0001096906-26-001545). Statements attributed to Brancous or Braemar are their claims, not findings. The closing prices are as stated in the PREC14A. Sums, shares of votes, differences and per-share conversions are our arithmetic. This is analysis of public documents, not investment, legal or tax advice.